Lemaitre Vascular [LMAT] vs Becton, Dickinson [BDX] Detailed Stock Comparison
Lemaitre Vascular
NASDAQ
Loading...
Becton, Dickinson
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lemaitre Vascular wins in 8 metrics, Becton, Dickinson wins in 12 metrics, with 0 ties. Becton, Dickinson appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lemaitre Vascular | Becton, Dickinson | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 42.85 | 35.46 | Becton, Dickinson |
| Price-to-Book Ratio | 5.48 | 2.18 | Becton, Dickinson |
| Debt-to-Equity Ratio | 51.25 | 75.93 | Lemaitre Vascular |
| PEG Ratio | 2.84 | 1.86 | Becton, Dickinson |
| EV/EBITDA | 28.60 | 12.52 | Becton, Dickinson |
| Profit Margin (TTM) | 20.08% | 7.41% | Lemaitre Vascular |
| Operating Margin (TTM) | 25.13% | 17.81% | Lemaitre Vascular |
| EBITDA Margin (TTM) | 25.13% | 17.81% | Lemaitre Vascular |
| Return on Equity | 13.81% | 6.18% | Lemaitre Vascular |
| Return on Assets (TTM) | 7.28% | 3.96% | Lemaitre Vascular |
| Free Cash Flow (TTM) | $37.16M | $3.07B | Becton, Dickinson |
| Dividend Yield | 0.98% | 1.80% | Becton, Dickinson |
| 1-Year Return | -4.11% | -18.73% | Lemaitre Vascular |
| Price-to-Sales Ratio (TTM) | 8.48 | 2.59 | Becton, Dickinson |
| Enterprise Value | $1.86B | $74.08B | Becton, Dickinson |
| EV/Revenue Ratio | 7.91 | 3.46 | Becton, Dickinson |
| Gross Profit Margin (TTM) | 70.02% | 47.81% | Lemaitre Vascular |
| Revenue per Share (TTM) | $10 | $74 | Becton, Dickinson |
| Earnings per Share (Diluted) | $2.05 | $5.46 | Becton, Dickinson |
| Beta (Stock Volatility) | 0.77 | 0.28 | Becton, Dickinson |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Lemaitre Vascular vs Becton, Dickinson Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lemaitre Vascular | -0.41% | 4.35% | -7.10% | 4.10% | 7.34% | -3.96% |
| Becton, Dickinson | -0.84% | 4.88% | 2.11% | 9.91% | -12.63% | -14.52% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lemaitre Vascular | -4.11% | 80.87% | 162.71% | 609.04% | 1,173.19% | 1,262.02% |
| Becton, Dickinson | -18.73% | -13.05% | -16.37% | 44.06% | 165.47% | 282.86% |
News Based Sentiment: Lemaitre Vascular vs Becton, Dickinson
Lemaitre Vascular
News based Sentiment: MIXED
The month presented a mixed bag for LeMaitre Vascular, with strong Q2 earnings and positive guidance offset by significant insider and institutional selling, and emerging bearish technical signals. This creates a complex investment narrative requiring careful consideration of both fundamental strength and shifting market sentiment.
Becton, Dickinson
News based Sentiment: POSITIVE
Becton Dickinson had a strong month driven by a significant earnings beat, upward guidance revision, and a strategic partnership focused on the growing pharmacy automation market. While insider selling exists, the overall narrative is positive, supported by high institutional ownership and positive analyst coverage.
Performance & Financial Health Analysis: Lemaitre Vascular vs Becton, Dickinson
| Metric | LMAT | BDX |
|---|---|---|
| Market Information | ||
| Market Cap | $1.99B | $55.67B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 164,532 | 1,421,540 |
| 90 Day Avg. Volume | 183,261 | 1,589,433 |
| Last Close | $87.49 | $191.99 |
| 52 Week Range | $71.42 - $109.58 | $163.33 - $251.99 |
| % from 52W High | -20.16% | -23.81% |
| All-Time High | $109.58 (Nov 25, 2024) | $287.32 (Jul 24, 2023) |
| % from All-Time High | -20.16% | -33.18% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.10% |
| Quarterly Earnings Growth | 0.17% | 0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.20% | 0.07% |
| Operating Margin (TTM) | 0.25% | 0.18% |
| Return on Equity (TTM) | 0.14% | 0.06% |
| Debt to Equity (MRQ) | 51.25 | 75.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $16.02 | $88.87 |
| Cash per Share (MRQ) | $14.11 | $2.64 |
| Operating Cash Flow (TTM) | $58.76M | $3.25B |
| Levered Free Cash Flow (TTM) | $37.70M | $3.37B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.98% | 1.80% |
| Last 12-Month Dividend | $0.92 | $3.03 |
Valuation & Enterprise Metrics Analysis: Lemaitre Vascular vs Becton, Dickinson
| Metric | LMAT | BDX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 42.85 | 35.46 |
| Forward P/E | 40.48 | 12.31 |
| PEG Ratio | 2.84 | 1.86 |
| Price to Sales (TTM) | 8.48 | 2.59 |
| Price to Book (MRQ) | 5.48 | 2.18 |
| Market Capitalization | ||
| Market Capitalization | $1.99B | $55.67B |
| Enterprise Value | $1.86B | $74.08B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.91 | 3.46 |
| Enterprise to EBITDA | 28.60 | 12.52 |
| Risk & Other Metrics | ||
| Beta | 0.77 | 0.28 |
| Book Value per Share (MRQ) | $16.02 | $88.87 |
Financial Statements Comparison: Lemaitre Vascular vs Becton, Dickinson
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LMAT | BDX |
|---|---|---|
| Revenue/Sales | $59.87M | $5.51B |
| Cost of Goods Sold | $18.45M | $2.88B |
| Gross Profit | $41.42M | $2.63B |
| Research & Development | $4.10M | $297.00M |
| Operating Income (EBIT) | $12.63M | $979.00M |
| EBITDA | $18.08M | $1.57B |
| Pre-Tax Income | $14.24M | $703.00M |
| Income Tax | $3.23M | $129.00M |
| Net Income (Profit) | $11.01M | $574.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LMAT | BDX |
|---|---|---|
| Cash & Equivalents | $25.34M | $667.00M |
| Total Current Assets | $408.11M | $8.67B |
| Total Current Liabilities | $24.75M | $7.69B |
| Long-Term Debt | $182.73M | $17.67B |
| Total Shareholders Equity | $347.57M | $25.24B |
| Retained Earnings | $151.58M | $16.15B |
| Property, Plant & Equipment | $41.34M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LMAT | BDX |
|---|---|---|
| Operating Cash Flow | $5.69M | $941.00M |
| Capital Expenditures | $-1.38M | N/A |
| Free Cash Flow | $7.66M | $35.00M |
| Debt Repayment | N/A | $-1.00M |
| Common Stock Repurchase | N/A | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | LMAT | BDX |
|---|---|---|
| Shares Short | 1.27M | 4.28M |
| Short Ratio | 7.04 | 2.41 |
| Short % of Float | 0.08% | 0.02% |
| Average Daily Volume (10 Day) | 164,532 | 1,421,540 |
| Average Daily Volume (90 Day) | 183,261 | 1,589,433 |
| Shares Outstanding | 22.55M | 289.10M |
| Float Shares | 20.85M | 286.00M |
| % Held by Insiders | 0.08% | 0.01% |
| % Held by Institutions | 0.95% | 0.92% |
Dividend Analysis & Yield Comparison: Lemaitre Vascular vs Becton, Dickinson
| Metric | LMAT | BDX |
|---|---|---|
| Last 12-Month Dividend | $0.92 | $3.03 |
| Last 12-Month Dividend Yield | 0.98% | 1.80% |
| 3-Year Avg Annual Dividend | $0.68 | $3.16 |
| 3-Year Avg Dividend Yield | 0.23% | 0.40% |
| 3-Year Total Dividends | $2.04 | $9.48 |
| Ex-Dividend Date | Aug 21, 2025 | Mar 10, 2025 |